Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi

suck pdf from helios

10.1007/s12072-020-10043-z

http://scihub22266oqcxt.onion/10.1007/s12072-020-10043-z
suck pdf from google scholar
32277387!7146012!32277387
unlimited free pdf from europmc32277387    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32277387  :  Publisher

suck abstract from ncbi

pmid32277387
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation #MMPMID32277387
  • Liu H; He X; Wang Y; Zhou S; Zhang D; Zhu J; He Q; Zhu Z; Li G; Sun L; Wang J; Cheng G; Liu Z; Lau G
  • Hepatol Int 2020[Jul]; 14 (4): 432-436 PMID32277387show ga
  • Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic.
  • |*Betacoronavirus[MESH]
  • |*Liver Transplantation[MESH]
  • |COVID-19[MESH]
  • |China[MESH]
  • |Coronavirus Infections/*complications/*diagnosis/therapy[MESH]
  • |Humans[MESH]
  • |Liver Diseases/*diagnosis/etiology/*therapy[MESH]
  • |Pandemics[MESH]
  • |Patient Selection[MESH]
  • |Pneumonia, Viral/*complications/*diagnosis/therapy[MESH]
  • |Practice Guidelines as Topic[MESH]
  • |SARS-CoV-2[MESH]
  • |Societies, Medical[MESH]
  • |Symptom Assessment[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    432 4.14 2020